Cabaletta Bio Inc (CABA)
10.17
+0.24
(+2.42%)
USD |
NASDAQ |
May 31, 16:00
10.17
0.00 (0.00%)
After-Hours: 20:00
Cabaletta Bio Free Cash Flow: -66.05M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -66.05M |
| December 31, 2023 | -54.24M |
| September 30, 2023 | -50.05M |
| June 30, 2023 | -48.39M |
| March 31, 2023 | -48.86M |
| December 31, 2022 | -48.83M |
| September 30, 2022 | -47.05M |
| June 30, 2022 | -44.92M |
| March 31, 2022 | -39.46M |
| Date | Value |
|---|---|
| December 31, 2021 | -35.28M |
| September 30, 2021 | -34.01M |
| June 30, 2021 | -30.32M |
| March 31, 2021 | -31.02M |
| December 31, 2020 | -27.40M |
| September 30, 2020 | -26.16M |
| June 30, 2020 | -23.09M |
| March 31, 2020 | -19.45M |
| December 31, 2019 | -16.74M |
Free Cash Flow Range, Past 5 Years
-66.05M
Minimum
Mar 2024
-16.74M
Maximum
Dec 2019
-38.41M
Average
-37.37M
Median
Free Cash Flow Benchmarks
| Editas Medicine Inc | -151.03M |
| ACADIA Pharmaceuticals Inc | 63.71M |
| Alnylam Pharmaceuticals Inc | 127.82M |
| Regeneron Pharmaceuticals Inc | 3.930B |
| Vertex Pharmaceuticals Inc | 3.479B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -23.99M |
| Cash from Investing (Quarterly) | -0.812M |
| Cash from Financing (Quarterly) | 6.855M |
| Free Cash Flow Per Share (Quarterly) | -0.503 |
| Free Cash Flow Yield | -14.33% |